These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
713 related articles for article (PubMed ID: 27629368)
1. Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders. Haroon E; Miller AH; Sanacora G Neuropsychopharmacology; 2017 Jan; 42(1):193-215. PubMed ID: 27629368 [TBL] [Abstract][Full Text] [Related]
2. The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Machado-Vieira R; Manji HK; Zarate CA Neuroscientist; 2009 Oct; 15(5):525-39. PubMed ID: 19471044 [TBL] [Abstract][Full Text] [Related]
3. Glia mechanisms in mood regulation: a novel model of mood disorders. Lee Y; Gaskins D; Anand A; Shekhar A Psychopharmacology (Berl); 2007 Mar; 191(1):55-65. PubMed ID: 17225169 [TBL] [Abstract][Full Text] [Related]
8. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Banasr M; Chowdhury GM; Terwilliger R; Newton SS; Duman RS; Behar KL; Sanacora G Mol Psychiatry; 2010 May; 15(5):501-11. PubMed ID: 18825147 [TBL] [Abstract][Full Text] [Related]
12. Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders. Nam HW; McIver SR; Hinton DJ; Thakkar MM; Sari Y; Parkinson FE; Haydon PG; Choi DS Alcohol Clin Exp Res; 2012 Jul; 36(7):1117-25. PubMed ID: 22309182 [TBL] [Abstract][Full Text] [Related]
13. The glutamatergic system as a target for neuropathic pain relief. Osikowicz M; Mika J; Przewlocka B Exp Physiol; 2013 Feb; 98(2):372-84. PubMed ID: 23002244 [TBL] [Abstract][Full Text] [Related]
14. Glia plasma membrane transporters: Key players in glutamatergic neurotransmission. Flores-Méndez M; Mendez-Flores OG; Ortega A Neurochem Int; 2016 Sep; 98():46-55. PubMed ID: 27083407 [TBL] [Abstract][Full Text] [Related]
15. Inflammation, glutamate, and glia in depression: a literature review. McNally L; Bhagwagar Z; Hannestad J CNS Spectr; 2008 Jun; 13(6):501-10. PubMed ID: 18567974 [TBL] [Abstract][Full Text] [Related]
16. Glial glutamate transporters: new actors in brain signaling. López-Bayghen E; Ortega A IUBMB Life; 2011 Oct; 63(10):816-23. PubMed ID: 21901813 [TBL] [Abstract][Full Text] [Related]
17. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. Steiner J; Bogerts B; Sarnyai Z; Walter M; Gos T; Bernstein HG; Myint AM World J Biol Psychiatry; 2012 Oct; 13(7):482-92. PubMed ID: 21707463 [TBL] [Abstract][Full Text] [Related]
18. Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders. Haroon E; Miller AH Mod Trends Pharmacopsychiatry; 2017; 31():37-55. PubMed ID: 28738353 [TBL] [Abstract][Full Text] [Related]
19. Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling. Liu Y; Wang S; Kan J; Zhang J; Zhou L; Huang Y; Zhang Y Curr Neuropharmacol; 2020; 18(4):260-276. PubMed ID: 31686629 [TBL] [Abstract][Full Text] [Related]
20. Cerebral Glutamate Regulation and Receptor Changes in Perioperative Neuroinflammation and Cognitive Dysfunction. Zhang Y; Chu JM; Wong GT Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]